After launching its student-run Rady Venture Fund three years ago, UCSD’s Rady School of Management says today it has invested $25,000 in its biggest deal so far—a $16 million Series B investment in Savara Pharmaceuticals of Austin, TX. Savara, founded in 2007, is in mid-stage development of an inhaled antibiotic to treat methicillin-resistant Staphylococcus aureus (MRSA) infections in patients with cystic fibrosis (CF). The Rady Venture Fund joined with members of Southern California’s Tech Coast Angels in a $7.4 million second tranche for Savara. […]
The State of Wisconsin Investment Board and Wisconsin Alumni Research Foundation are creating an early-stage venture capital fund focused on information technology.
Called 4490 Ventures, a reference to the 44° N latitude and 90° W longitude lines that approximate the center of the state of Wisconsin, the $30 million fund will focus on early-stage companies primarily in Wisconsin. The private fund, capitalized jointly by SWIB and WARF, is intended to generate attractive returns and build value for state retirement fund participants and WARF’s primary beneficiary, the University of Wisconsin–Madison. […]
Clearside Biomedical, Inc. an Atlanta-based ophthalmic pharmaceutical company launched from research at Emory University and the Georgia Institute of Technology, has received $7.9 million in funding to continue drug and technology development for treatment of ocular diseases.
The new funding is in addition to a $4 million venture capital investment received by Clearside Biomedical in early 2012 that served as the foundation for the startup company. […]
A statewide network designed to accelerate innovation and economic growth has awarded $861,086 to 18 university research projects across the commonwealth.
The Virginia Innovation Partnership, created last fall as part of the U.S. Department of Commerce’s i6 Challenge, provides proof-of-concept funding to advance early-stage research, also connecting academic researchers with mentors, corporations and investors to accelerate commercialization of the new discoveries. […]
IP Shakti adds a CEO in Residence program to support seed fund for biomedical and life science innovations
PRINCETON, N.J., March 21, 2013 /PRNewswire/ – IP Shakti (www.ipshakti.com) has now launched a CEO-In-Residence (CIR) program with their existing gap fund and technology portfolio. “Management, Funding and Technology form the 3-legged stool a start-up company needs to bring a technology to the marketplace. Many Universities have the technology, and perhaps the management through an entrepreneurship program, but at IP Shakti we can provide the funding as well as the experienced management,” explains Dr. Dipanjan Nag, CEO and President of IP Shakti. […]
The city of Philadelphia announced Tuesday that its Startup PHL Seed Fundwill be run by one of the top seed investors in the country — for free.
First Round Capital, the University City-based seed-stage venture-capital firm co-founded by tech entrepreneur and investorJosh Kopelman, will run the fund and invest $3 million in it. The Philadelphia Industrial Development Corp. also will invest $3 million in the fund, which is part of an effort by the city of Philadelphia to encourage startups to set up shop and grow within its borders.
First Round Capital has agreed not to take a management fee — or any other compensation — for running the fund. […]
The University of Toronto computer science department confirmed today that Google has acquired one of their startups lead by professor Geoffrey Hinton. DNNresearch Inc. was incorporated in 2012 and includes two of Hinton’s graduate students, Alex Krizhevsky and Ilya Sutskever.
The startup focuses on deep neural networks (or “deep learning”) and will assist Google in the realm of contextual recognition of voice and images. For the search giant this kind of research is highly sought after as more and more people look up concepts on their mobile devices. […]
Two life sciences companies that are commercializing Purdue University innovations can receive up to $250,000 in investments from the Emerging Innovations Fund, an evergreen fund created to accelerate the commercialization of early-stage discoveries. […]